• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

R 环介导的单链 DNA 断裂在短期暴露于组蛋白去乙酰化酶抑制剂罗米地辛后积累。

R-Loop-Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin.

机构信息

Division of Hematology and Oncology, Department of Medicine, Columbia University, New York, New York.

University of Copenhagen, Copenhagen, Denmark.

出版信息

Mol Cancer Res. 2021 Aug;19(8):1361-1374. doi: 10.1158/1541-7786.MCR-20-0833. Epub 2021 May 28.

DOI:10.1158/1541-7786.MCR-20-0833
PMID:34050002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8974437/
Abstract

Histone deacetylase inhibitors (HDACi) induce hyperacetylation of histones by blocking HDAC catalytic sites. Despite regulatory approvals in hematological malignancies, limited solid tumor clinical activity has constrained their potential, arguing for better understanding of mechanisms of action (MOA). Multiple activities of HDACis have been demonstrated, dependent on cell context, beyond the canonical induction of gene expression. Here, using a clinically relevant exposure duration, we established DNA damage as the dominant signature using the NCI-60 cell line database and then focused on the mechanism by which hyperacetylation induces DNA damage. We identified accumulation of DNA-RNA hybrids (R-loops) following romidepsin-induced histone hyperacetylation, with single-stranded DNA (ssDNA) breaks detected by single-cell electrophoresis. Our data suggest that transcription-coupled base excision repair (BER) is involved in resolving ssDNA breaks that, when overwhelmed, evolve to lethal dsDNA breaks. We show that inhibition of BER proteins such as PARP will increase dsDNA breaks in this context. These studies establish accumulation of R-loops as a consequence of romidepsin-mediated histone hyperacetylation. We believe that the insights provided will inform design of more effective combination therapy with HDACis for treatment of solid tumors. IMPLICATIONS: Key HDAC inhibitor mechanisms of action remain unknown; we identify accumulation of DNA-RNA hybrids (R-loops) due to chromatin hyperacetylation that provokes single-stranded DNA damage as a first step toward cell death.

摘要

组蛋白去乙酰化酶抑制剂(HDACi)通过阻断 HDAC 催化位点来诱导组蛋白的超乙酰化。尽管在血液恶性肿瘤中获得了监管批准,但有限的实体瘤临床活性限制了它们的潜力,这表明需要更好地了解作用机制(MOA)。已经证明 HDACi 具有多种活性,这取决于细胞环境,而不仅仅是经典的基因表达诱导。在这里,我们使用临床相关的暴露持续时间,使用 NCI-60 细胞系数据库确定了 DNA 损伤是主要特征,然后专注于组蛋白超乙酰化诱导 DNA 损伤的机制。我们发现,在罗米地辛诱导的组蛋白超乙酰化后,DNA-RNA 杂交(R 环)会积累,通过单细胞电泳检测到单链 DNA(ssDNA)断裂。我们的数据表明,转录偶联的碱基切除修复(BER)参与修复 ssDNA 断裂,当 BER 无法承受时,ssDNA 断裂会演变成致命的双链 DNA 断裂。我们表明,在这种情况下抑制 BER 蛋白(如 PARP)会增加双链 DNA 断裂。这些研究确立了 R 环的积累是罗米地辛介导的组蛋白超乙酰化的结果。我们相信,提供的这些见解将为设计更有效的与 HDACi 的联合治疗方案提供信息,以治疗实体瘤。意义:关键的 HDAC 抑制剂作用机制仍不清楚;我们确定由于染色质超乙酰化导致的 DNA-RNA 杂交(R 环)的积累,这会引发单链 DNA 损伤,作为细胞死亡的第一步。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1523/8974437/2eb794fa5876/molcanres-19-1361-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1523/8974437/051e070f8d31/molcanres-19-1361-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1523/8974437/efeb9d1d326c/molcanres-19-1361-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1523/8974437/cf3c9a5cc033/molcanres-19-1361-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1523/8974437/229e3e6833a1/molcanres-19-1361-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1523/8974437/d0b19fc09f58/molcanres-19-1361-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1523/8974437/824fa1187f78/molcanres-19-1361-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1523/8974437/2eb794fa5876/molcanres-19-1361-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1523/8974437/051e070f8d31/molcanres-19-1361-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1523/8974437/efeb9d1d326c/molcanres-19-1361-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1523/8974437/cf3c9a5cc033/molcanres-19-1361-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1523/8974437/229e3e6833a1/molcanres-19-1361-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1523/8974437/d0b19fc09f58/molcanres-19-1361-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1523/8974437/824fa1187f78/molcanres-19-1361-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1523/8974437/2eb794fa5876/molcanres-19-1361-g007.jpg

相似文献

1
R-Loop-Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin.R 环介导的单链 DNA 断裂在短期暴露于组蛋白去乙酰化酶抑制剂罗米地辛后积累。
Mol Cancer Res. 2021 Aug;19(8):1361-1374. doi: 10.1158/1541-7786.MCR-20-0833. Epub 2021 May 28.
2
Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir.罗米地辛抑制 I 类组蛋白去乙酰化酶能强力诱导 EBV 裂解周期,并与更昔洛韦联合介导增强的细胞死亡。
Int J Cancer. 2016 Jan 1;138(1):125-36. doi: 10.1002/ijc.29698. Epub 2015 Aug 11.
3
The Histone Deacetylase Inhibitor Romidepsin Spares Normal Tissues While Acting as an Effective Radiosensitizer in Bladder Tumors in Vivo.组蛋白去乙酰化酶抑制剂罗米地辛在体内作为有效的放射增敏剂,对正常组织具有保护作用,同时对膀胱肿瘤具有疗效。
Int J Radiat Oncol Biol Phys. 2020 May 1;107(1):212-221. doi: 10.1016/j.ijrobp.2020.01.015. Epub 2020 Jan 25.
4
Romidepsin induces cell cycle arrest, apoptosis, histone hyperacetylation and reduces matrix metalloproteinases 2 and 9 expression in bortezomib sensitized non-small cell lung cancer cells.罗米地辛诱导细胞周期停滞、细胞凋亡,使组蛋白乙酰化,并降低硼替佐米增敏的非小细胞肺癌细胞中基质金属蛋白酶 2 和 9 的表达。
Biomed Pharmacother. 2014 Apr;68(3):327-34. doi: 10.1016/j.biopha.2014.01.002. Epub 2014 Jan 15.
5
Molecular and biologic analysis of histone deacetylase inhibitors with diverse specificities.具有不同特异性的组蛋白去乙酰化酶抑制剂的分子和生物学分析。
Mol Cancer Ther. 2013 Dec;12(12):2709-21. doi: 10.1158/1535-7163.MCT-13-0626. Epub 2013 Oct 3.
6
Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach.组蛋白去乙酰化酶抑制剂诱导的膀胱癌细胞死亡与染色质修饰及修饰蛋白表达相关:蛋白质组学方法
Int J Oncol. 2016 Jun;48(6):2591-607. doi: 10.3892/ijo.2016.3478. Epub 2016 Apr 7.
7
A focus on the preclinical development and clinical status of the histone deacetylase inhibitor, romidepsin (depsipeptide, Istodax(®)).专注于组蛋白去乙酰化酶抑制剂罗米地辛(司替戊醇,Istodax(®))的临床前开发和临床状况。
Epigenomics. 2012 Oct;4(5):571-89. doi: 10.2217/epi.12.52.
8
Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.组蛋白去乙酰化酶抑制剂与阿扎胞苷联合对食管癌细胞的选择性抑制作用
Epigenetics. 2015;10(5):431-45. doi: 10.1080/15592294.2015.1039216.
9
Molecular mechanistic pathways underlying the anticancer therapeutic efficiency of romidepsin.罗米地辛抗癌治疗效果的分子机制途径。
Biomed Pharmacother. 2023 Aug;164:114774. doi: 10.1016/j.biopha.2023.114774. Epub 2023 May 22.
10
Interactions between bortezomib and romidepsin and belinostat in chronic lymphocytic leukemia cells.硼替佐米与罗米地辛及贝利司他在慢性淋巴细胞白血病细胞中的相互作用。
Clin Cancer Res. 2008 Jan 15;14(2):549-58. doi: 10.1158/1078-0432.CCR-07-1934.

引用本文的文献

1
FK228 reshapes tumor microenvironment to enhance anti-PD-L1 efficacy.FK228重塑肿瘤微环境以增强抗PD-L1疗效。
Oncogene. 2025 Sep 12. doi: 10.1038/s41388-025-03558-y.
2
Mechanisms underlining R-loop biology and implications for human disease.R环生物学的潜在机制及其对人类疾病的影响。
Front Cell Dev Biol. 2025 Feb 21;13:1537731. doi: 10.3389/fcell.2025.1537731. eCollection 2025.
3
Synergistic Cytotoxicity of Histone Deacetylase and Poly-ADP Ribose Polymerase Inhibitors and Decitabine in Breast and Ovarian Cancer Cells: Implications for Novel Therapeutic Combinations.

本文引用的文献

1
Epigenetic Therapies for Cancer.癌症的表观遗传疗法
N Engl J Med. 2020 Aug 13;383(7):650-663. doi: 10.1056/NEJMra1805035.
2
The DNA damage response acts as a safeguard against harmful DNA-RNA hybrids of different origins.DNA 损伤反应可作为针对不同来源的有害 DNA-RNA 杂交体的保护机制。
EMBO Rep. 2019 Sep;20(9):e47250. doi: 10.15252/embr.201847250. Epub 2019 Jul 24.
3
High-resolution, strand-specific R-loop mapping via S9.6-based DNA-RNA immunoprecipitation and high-throughput sequencing.基于 S9.6 的 DNA-RNA 免疫沉淀和高通量测序进行高分辨率、链特异性 R 环作图。
组蛋白去乙酰化酶和多聚(ADP-核糖)聚合酶抑制剂与地西他滨在乳腺癌和卵巢癌细胞中的协同细胞毒性:对新型治疗联合的启示。
Int J Mol Sci. 2024 Aug 26;25(17):9241. doi: 10.3390/ijms25179241.
4
M6A-methylated circPOLR2B forms an R-loop and regulates the biological behavior of glioma stem cells through positive feedback loops.m6A甲基化的环状POLR2B形成R环,并通过正反馈环调节胶质瘤干细胞的生物学行为。
Cell Death Dis. 2024 Aug 1;15(8):554. doi: 10.1038/s41419-024-06946-6.
5
Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors.恩替诺特治疗复发或难治性腹部神经内分泌肿瘤患者。
Oncologist. 2024 Sep 6;29(9):817-e1213. doi: 10.1093/oncolo/oyae118.
6
Looping forward: exploring R-loop processing and therapeutic potential.向前循环:探索R环加工及治疗潜力。
FEBS Lett. 2025 Jan;599(2):244-266. doi: 10.1002/1873-3468.14947. Epub 2024 Jun 6.
7
R-loops, type I topoisomerases and cancer.R环、I型拓扑异构酶与癌症
NAR Cancer. 2023 Mar 3;5(1):zcad013. doi: 10.1093/narcan/zcad013. eCollection 2023 Mar.
8
NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase Inhibitor.NOXA增强新型组蛋白去乙酰化酶抑制剂诱导的细胞凋亡。
Cancers (Basel). 2023 Jul 17;15(14):3650. doi: 10.3390/cancers15143650.
9
R-Loops and R-Loop-Binding Proteins in Cancer Progression and Drug Resistance.R 环和 R 环结合蛋白在癌症进展和耐药中的作用。
Int J Mol Sci. 2023 Apr 11;24(8):7064. doi: 10.3390/ijms24087064.
10
The chromatin-associated RNAs in gene regulation and cancer.染色质相关 RNA 在基因调控和癌症中的作用。
Mol Cancer. 2023 Feb 7;22(1):27. doi: 10.1186/s12943-023-01724-y.
Nat Protoc. 2019 Jun;14(6):1734-1755. doi: 10.1038/s41596-019-0159-1. Epub 2019 May 3.
4
R-loop formation during S phase is restricted by PrimPol-mediated repriming.S 期内 R 环的形成受到 PrimPol 介导的重新引发的限制。
EMBO J. 2019 Feb 1;38(3). doi: 10.15252/embj.201899793. Epub 2018 Nov 26.
5
High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects.高 PARP-1 表达预示急性髓系白血病不良预后,PARP-1 抑制剂与 SAHA-苯达莫司汀联合抑制协同增强抗肿瘤作用。
EBioMedicine. 2018 Dec;38:47-56. doi: 10.1016/j.ebiom.2018.11.025. Epub 2018 Nov 22.
6
Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma.皮肤 T 细胞淋巴瘤中组蛋白去乙酰化酶抑制剂的现状。
Am J Clin Dermatol. 2018 Dec;19(6):805-819. doi: 10.1007/s40257-018-0380-7.
7
Human proteins that interact with RNA/DNA hybrids.与 RNA/DNA 杂交体相互作用的人类蛋白质。
Genome Res. 2018 Sep;28(9):1405-1414. doi: 10.1101/gr.237362.118. Epub 2018 Aug 14.
8
Dihydrocoumarin, an HDAC Inhibitor, Increases DNA Damage Sensitivity by Inhibiting Rad52.二氢香豆素,一种组蛋白去乙酰化酶抑制剂,通过抑制 Rad52 增加 DNA 损伤敏感性。
Int J Mol Sci. 2017 Dec 7;18(12):2655. doi: 10.3390/ijms18122655.
9
Human THO-Sin3A interaction reveals new mechanisms to prevent R-loops that cause genome instability.人类THO与Sin3A的相互作用揭示了预防导致基因组不稳定的R环的新机制。
EMBO J. 2017 Dec 1;36(23):3532-3547. doi: 10.15252/embj.201797208. Epub 2017 Oct 26.
10
Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trials.罗米地辛对老年外周T细胞淋巴瘤患者有效且耐受性良好:两项II期试验分析
Leuk Lymphoma. 2017 Oct;58(10):2335-2341. doi: 10.1080/10428194.2017.1295143. Epub 2017 Mar 7.